1. Home
  2. OXBR vs HKPD Comparison

OXBR vs HKPD Comparison

Compare OXBR & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxbridge Re Holdings Limited

OXBR

Oxbridge Re Holdings Limited

N/A

Current Price

$0.99

Market Cap

8.0M

Sector

Finance

ML Signal

N/A

HKPD

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

N/A

Current Price

$0.53

Market Cap

6.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OXBR
HKPD
Founded
2013
2016
Country
Cayman Islands
Hong Kong
Employees
4
27
Industry
Property-Casualty Insurers
Other Pharmaceuticals
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
6.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OXBR
HKPD
Price
$0.99
$0.53
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
23.0K
90.4K
Earning Date
05-11-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$80.09
N/A
Revenue Next Year
$85.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.37
52 Week High
$2.85
$2.58

Technical Indicators

Market Signals
Indicator
OXBR
HKPD
Relative Strength Index (RSI) 57.16 37.04
Support Level $0.99 $0.45
Resistance Level $1.05 $0.71
Average True Range (ATR) 0.07 0.07
MACD 0.00 -0.01
Stochastic Oscillator 90.00 29.67

Price Performance

Historical Comparison
OXBR
HKPD

About OXBR Oxbridge Re Holdings Limited

Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer that provides reinsurance solutions through its subsidiary. The company focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. It specializes in underwriting medium-frequency, high-severity risks where insufficient data exists to effectively analyze the risk/return profile of reinsurance contracts. The company generates revenue from three principal sources: premiums assumed from reinsurance on property and casualty business; income from investments, including unrealized gains or losses on other investments; and income from SurancePlus management fees.

About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Share on Social Networks: